Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$17.19 - $24.34 $123,768 - $175,248
-7,200 Reduced 21.05%
27,000 $596,000
Q1 2023

May 15, 2023

BUY
$17.67 - $26.07 $386,973 - $570,933
21,900 Added 178.05%
34,200 $743,000
Q4 2022

Feb 14, 2023

BUY
$16.95 - $25.07 $208,485 - $308,361
12,300 New
12,300 $223,000
Q2 2022

Aug 15, 2022

SELL
$10.54 - $24.2 $1.14 Million - $2.62 Million
-108,459 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$20.81 - $37.29 $2.26 Million - $4.04 Million
108,459 New
108,459 $2.47 Million
Q3 2021

Nov 15, 2021

SELL
$42.03 - $60.5 $332,037 - $477,950
-7,900 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$29.51 - $44.62 $3.35 Million - $5.06 Million
-113,510 Reduced 93.49%
7,900 $352,000
Q1 2021

May 17, 2021

BUY
$32.95 - $44.24 $3.04 Million - $4.08 Million
92,310 Added 317.22%
121,410 $4.37 Million
Q4 2020

Feb 16, 2021

BUY
$27.5 - $45.75 $800,250 - $1.33 Million
29,100 New
29,100 $1.16 Million
Q3 2020

Nov 16, 2020

SELL
$16.04 - $28.94 $668,659 - $1.21 Million
-41,687 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$9.2 - $17.06 $383,520 - $711,180
41,687 New
41,687 $682,000
Q1 2019

May 15, 2019

SELL
$10.9 - $21.26 $680,901 - $1.33 Million
-62,468 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$9.5 - $17.17 $412,005 - $744,645
-43,369 Reduced 40.98%
62,468 $751,000
Q3 2018

Nov 14, 2018

BUY
$14.99 - $25.48 $1.59 Million - $2.7 Million
105,837 New
105,837 $1.85 Million
Q2 2018

Aug 14, 2018

SELL
$6.18 - $13.49 $106,030 - $231,447
-17,157 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.73 - $6.03 $3,580 - $4,564
757 Added 4.62%
17,157 $88,000
Q4 2017

Feb 14, 2018

BUY
$4.98 - $6.9 $81,672 - $113,160
16,400
16,400 $98,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.16B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.